Amid tariff turmoil, Novartis commits to spending $23B on US manufacturing
Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the
Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the
No posts found.